IMP
Process View
modified amino acid transport
The directed movement of modified amino acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "modified amino acid transport"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| TBC1D10A | TBC1 domain family, member 10A | 1.000 | ||
| EZR | ezrin | 0.999 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.999 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.998 | ||
| PDZK1 | PDZ domain containing 1 | 0.917 | ||
| ADRB2 | adrenergic, beta-2-, receptor, surface | 0.872 | ||
| SLC7A5 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 | 0.815 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.702 | ||
| SLC3A2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 | 0.427 | ||
| GOPC | golgi-associated PDZ and coiled-coil motif containing | 0.277 | ||
| SLC7A1 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | 0.252 | ||
| AARS | alanyl-tRNA synthetase | 0.209 | ||
| P2RY1 | purinergic receptor P2Y, G-protein coupled, 1 | 0.202 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.200 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.161 | ||
| USP50 | ubiquitin specific peptidase 50 | 0.149 | ||
| MSN | moesin | 0.130 | ||
| NF2 | neurofibromin 2 (merlin) | 0.127 | ||
| EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | 0.096 | ||
| SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 0.088 | Human | |
| PCK2 | phosphoenolpyruvate carboxykinase 2 (mitochondrial) | 0.087 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.077 | ||
| CSK | c-src tyrosine kinase | 0.065 | ||
| CLCN3 | chloride channel 3 | 0.056 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.052 | ||
| HYOU1 | hypoxia up-regulated 1 | 0.049 | ||
| SSR1 | signal sequence receptor, alpha | 0.046 | ||
| CANX | calnexin | 0.043 | ||
| MPDU1 | mannose-P-dolichol utilization defect 1 | 0.040 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.035 | ||
| TMEM173 | transmembrane protein 173 | 0.033 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.033 | Human | |
| NEK6 | NIMA (never in mitosis gene a)-related kinase 6 | 0.027 | ||
| YARS | tyrosyl-tRNA synthetase | 0.025 | ||
| SLC38A7 | solute carrier family 38, member 7 | 0.022 | ||
| PROC | protein C (inactivator of coagulation factors Va and VIIIa) | 0.021 | ||
| VEGFA | vascular endothelial growth factor A | 0.021 | ||
| BCR | breakpoint cluster region | 0.021 | ||
| ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.021 | ||
| PHGDH | phosphoglycerate dehydrogenase | 0.019 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.019 | ||
| PYCR1 | pyrroline-5-carboxylate reductase 1 | 0.019 | ||
| ELANE | elastase, neutrophil expressed | 0.019 | ||
| SHMT2 | serine hydroxymethyltransferase 2 (mitochondrial) | 0.018 | ||
| TRIB3 | tribbles homolog 3 (Drosophila) | 0.018 | ||
| ACP2 | acid phosphatase 2, lysosomal | 0.018 | ||
| P2RY2 | purinergic receptor P2Y, G-protein coupled, 2 | 0.017 | ||
| GJB1 | gap junction protein, beta 1, 32kDa | 0.017 | ||
| LAMC3 | laminin, gamma 3 | 0.017 | ||
| PLG | plasminogen | 0.016 | ||
| KLK3 | kallikrein-related peptidase 3 | 0.016 | ||
| GADD45G | growth arrest and DNA-damage-inducible, gamma | 0.015 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.015 | ||
| TNNT1 | troponin T type 1 (skeletal, slow) | 0.013 | ||
| GNA11 | guanine nucleotide binding protein (G protein), alpha 11 (Gq class) | 0.013 | ||
| AZGP1 | alpha-2-glycoprotein 1, zinc-binding | 0.013 | ||
| SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 0.012 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.012 | Human | |
| PROZ | protein Z, vitamin K-dependent plasma glycoprotein | 0.012 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.012 | ||
| GARS | glycyl-tRNA synthetase | 0.011 | ||
| HPX | hemopexin | 0.011 | ||
| FGL1 | fibrinogen-like 1 | 0.011 | ||
| SLC6A12 | solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 | 0.011 | ||
| MARS | methionyl-tRNA synthetase | 0.011 | ||
| SEC61A1 | Sec61 alpha 1 subunit (S. cerevisiae) | 0.011 | ||
| MBOAT7 | membrane bound O-acyltransferase domain containing 7 | 0.010 |